• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Model Number D134805
Device Problems Device Contamination with Body Fluid (2317); Temperature Problem (3022); Patient Device Interaction Problem (4001)
Patient Problem Stroke/CVA (1770)
Event Date 12/15/2021
Event Type  Injury  
Manufacturer Narrative
If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Event Description
It was reported that a male patient born (b)(6) underwent an atrial fibrillation (afib) ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter and the patient suffered a cerebrovascular accident requiring prolonged hospitalization.It was reported by the caller that during use of the thermocool® smart touch® sf bi-directional navigation catheter had char on the tip of the catheter.Physician cleaned char from tip, checked irrigation flow and confirmed performance of irrigation and continued use of catheter.The catheter was not replaced and the procedure was continued.After the procedure the patient was slow to wake up, was not moving their right side and was going to have a ct- scan.The patient demonstrates inability to talk and right- side weakness/flaccidity as of last report from physician.The patient required extended hospitalization because of the adverse event, remains in hospital with described symptoms.Physician did not indicate opinion on cause of the adverse event.Per the physician, patient history includes recent ((b)(6) 2021) mitral valve repair 3 months prior with laa closure device (noted on tee to be incomplete closure with residual blood flow in and out of appendage.Patient had perioperative stroke with recovery of symptoms at that time.A smartablate generator used during the case failed to display any temperature on several occasions but physician declined offer to troubleshoot the catheter or change the catheter.Generator parameters were set to power control mode.35-45 watts with nominal temperature cut off settings of 40 celsius.Temperature range during ablations were noted at approximately 20-30 celsius.Patient's activated clotting time (act) was kept between 400-500 throughout case.The carto 3 workstation did not present any errors.The customer¿s reported no temperature displayed is not considered to be mdr reportable the potential that it could cause or contribute to a death or serious injury, or other significant adverse event is remote.
 
Manufacturer Narrative
On 10-jan-2022, additional information was received clarifying that the b3.Date of event was actually (b)(6) 2021 and not (b)(6) 2021 as previously reported.The field has been updated appropriately.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.#(b)(4).
 
Manufacturer Narrative
On (b)(6)-2022, the bwi product analysis lab received the complaint device for evaluation.The product analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Manufacturer Narrative
It was reported that a male patient born (b)(6)1984 underwent an atrial fibrillation (afib) ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter and the patient suffered a cerebrovascular accident requiring prolonged hospitalization.It was reported by the caller that during use of the thermocool® smart touch® sf bi-directional navigation catheter had char on the tip of the catheter.Physician cleaned char from tip, checked irrigation flow and confirmed performance of irrigation and continued use of catheter.The catheter was not replaced and the procedure was continued.It was also reported the smartablate generator used during the case failed to display any temperature on several occasions but physician declined offer to troubleshoot the catheter or change the catheter.After the procedure the patient was slow to wake up, was not moving their right side and was going to have a ct- scan.The patient demonstrates inability to talk and right- side weakness/flaccidity as of last report from physician.The patient required extended hospitalization because of the adverse event.Device evaluation details: the product was returned to biosense webster inc.(bwi) for evaluation and the evaluation has been completed.Bwi conducted a visual inspection and an evaluation of all features of the catheter.Visual analysis of the returned sample revealed that no damage or anomalies were observed on the thermocool® smart touch® sf bi-directional navigation catheter.Per the event, several tests were performed.The force, magnetic and temperature features were tested, and no issues were observed.In addition, the product was deflecting and irrigating correctly.No malfunctions were observed during the product analysis.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.As part of bwi¿s quality process, all devices are manufactured, inspected, and released to approved specifications.The catheter passed all specifications.The root cause of the adverse event remains unknown.The root cause of char on tip remains unknown.The evaluation determined that char is a physical phenomenon of rf.Directions for use: increase the irrigation to a high flow rate starting up to 5 seconds before the onset of rf energy delivery and maintain this higher flow rate until 5 seconds after termination of the energy application.For power levels up to 30w, a high flow rate of 8ml/min should be used.For power levels between 31-45wa high flow rate of 15ml/min should be used.Do not use this catheter without irrigation flow.There may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Explanation of codes: investigation findings: no device problem found (c19) / investigation conclusions: no problem detected (d14) were selected as related to the reported adverse event and no temperature display issues.Investigation findings: problem due to thrombosis activation (c010604) / investigation conclusions: cause traced to user (d11) / cautery tip (g01002)were selected as related to the reported char.Manufacturer's ref.# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER
Type of Device
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
gabriel alfageme
31 technology dr
irvine, CA 92618
9497898687
MDR Report Key13203629
MDR Text Key283485488
Report Number2029046-2022-00063
Device Sequence Number1
Product Code LPB
UDI-Device Identifier10846835010183
UDI-Public10846835010183
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 03/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/15/2022
Device Model NumberD134805
Device Catalogue NumberD134805
Device Lot Number30648672L
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/13/2022
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/15/2021
Initial Date FDA Received01/10/2022
Supplement Dates Manufacturer Received01/10/2022
01/13/2022
02/07/2022
Supplement Dates FDA Received01/11/2022
02/01/2022
03/04/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/16/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CARTO 3 SYSTEM; SMARTABLATE GENERATOR KIT-US; SMARTABLATE PUMP KIT-US
Patient Outcome(s) Life Threatening; Hospitalization;
Patient Age37 YR
Patient SexMale
-
-